FDA Adverse Event Malfunction Summary report: N

UNKNOWN CERECYTE MICROCOIL

MDR report key: 6647689 · Received June 16, 2017

Report

Report Number
2954740-2017-00143
Event Type
Malfunction
Date Received
June 16, 2017
Date of Event
January 1, 2009
Report Date
May 23, 2017
Manufacturer
MEDOS INTERNATIONAL SARL
Product Code
HCG
PMA / PMN Number
K022420
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PROCODE: KRD/HCG. CONCOMITANT MEDICAL PRODUCTS: 30 MM X 4.5 MM NEUROFORM 3 STENT (BOSTON SCIENTIFIC/TARGET, (B)(4)). UNKNOWN PART NUMBER, ATTEMPTS TO OBTAIN PRODUCT PART NUMBER WERE UNSUCCESSFUL, UDI UNAVAILABLE. DATE OF EVENT, PRODUCT CODE, AND LOT NUMBER NOT AVAILABLE. THREE ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION FROM THE AUTHOR WERE UNSUCCESSFUL. THIS IS AN INITIAL/FINAL MDR REPORT. CONCLUSION: THE DEVICE WAS NOT AVAILABLE FOR ANALYSIS. IN ADDITION, THE LOT NUMBER WAS NOT PROVIDED; THEREFORE, A DHR COULD NOT BE PERFORMED. PROTRUSION OF THE COIL OUT OF THE ANEURYSM IS A KNOWN PROCEDURAL COMPLICATION ASSOCIATED WITH COIL EMBOLIZATION PROCEDURES. THE ROOT CAUSE OF THE EVENT COULD NOT BE CONCLUSIVELY DETERMINED; HOWEVER, ANEURYSM CHARACTERISTICS MAY HAVE CONTRIBUTED TO THE EVENT. COIL PROTRUSION FROM THE ANEURYSM IS MORE COMMON WITH WIDE NECK ANEURYSMS AND THE STENT IS INTENDED TO HELP MAINTAIN THE COIL WITHIN THE ANEURYSM. SINCE THERE WAS NO EVIDENCE TO SUGGEST THE EVENT WAS RELATED TO A MANUFACTURING ISSUE, NO CORRECTIVE ACTIONS WILL BE TAKEN AT THIS TIME.

Description of Event or Problem · 1

IN THE LITERATURE ARTICLE ¿COIL MIGRATION THROUGH A NEUROFORM 3 STENT DURING ENDOVASCULAR COILING¿ BY A. O¿HARE, J.THORNTON, P. BRENNAN, PUBLISHED INTERVENTIONAL NEURORADIOLOGY 15: 219-222, 2009, THE AUTHORS PRESENT A CASE WHERE A CODMAN CERECYTE COIL (CATALOG AND LOT UNKNOWN) PROTRUDED INTO THE PARENT ARTERY THROUGH A NON-CODMAN STENT. A (B)(6) WOMAN PRESENTED AFTER AN INCIDENTAL FINDING OF THREE CEREBRAL ANEURYSMS. THE TWO RIGHT CAROTID ANEURYSMS WERE SUCCESSFULLY COILED ON TWO SEPARATE OCCASIONS. A LEFT PERIOPHTHALMIC ANEURYSM WAS TOO BROAD-NECKED TO COIL UNASSISTED AND THEREFORE A 30 MM X 4.5 MM NEUROFORM 3 STENT (BOSTON SCIENTIFIC/TARGET, (B)(4)) WAS PLACED ACROSS THE ANEURYSM NECK. THE PROCEDURE WAS UNCOMPLICATED WITH THE PLATINUM STRUTS IN A SATISFACTORY POSITION, AND THE PATIENT RETURNED HOME ON DUAL ANTIPLATELET THERAPY TO RETURN IN SIX WEEKS FOR ENDOVASCULAR COILING OF THIS ANEURYSM. SIX WEEKS LATER, ANGIOGRAPHY SHOWED THAT THE ANEURYSM WAS UNCHANGED AND MEASURED 4 X 2.5 MM. THE STENT REMAINED IN ITS CORRECT POSITION AND A 0.17 COURIER CATHETER WAS ADVANCED OVER A TRANSCEND WIRE TO THE ANEURYSM. THE CATHETER WAS SUCCESSFULLY PLACED IN THE ANEURYSM AFTER SEVERAL ATTEMPTS. THE INITIAL COIL WAS ADVANCED (CERECYTE 2.5 X 3.3 CM). DESPITE THE OPTIMAL WORKING ANGLE, DIFFICULTY AROSE IN ASCERTAINING WHETHER THIS FIRST COIL WAS COMPLETELY INSIDE THE ANEURYSM OR WHETHER SOME OF THE LOOPS PROTRUDED INTO THE PARENT VESSEL. A LOW CONTRAST DYNACT (SIEMENS MEDICAL SOLUTIONS, FORCHEIM, GERMANY) WAS UNABLE TO IDENTIFY THE STRUTS OF THE STENT. THE CT DID SHOW PROBABLE COIL HERNIATION THROUGH THE STENT INTO THE CAROTID AND THE COIL WAS REMOVED. NO FURTHER INFORMATION WAS PROVIDED ABOUT THE CODMAN CERECYTE COIL, INCLUDING CATALOG AND LOT NUMBER OR DATE OF PROCEDURE. THE MICROCATHETER WAS REPOSITIONED AND ANOTHER COIL (HYDROCOIL, 2 X 4CM, MICROVENTION, ALISO VIEJO, CA, USA) PLACED WHICH HAD A MORE FAVOURABLE APPEARANCE. THIS WAS DEPLOYED AND FOLLOWED BY A SECOND COIL (HYDROCOIL, 2 X 3CM) AT THE SAME CATHETER POSITION. AS THE SECOND COIL NEARED THE POINT OF DETACHMENT THE FIRST COIL HERNIATED IN ITS ENTIRETY INTO THE PARENT VESSEL. THE SECOND COIL WAS RETRACTED AND THE HERNIATED COIL DRIFTED TOWARD THE MIDDLE CEREBRAL ARTERY (MCA). ATTEMPTS WERE MADE TO RETRIEVE THE COIL USING THE MERCI DEVICE (CONCENTRIC MEDICAL, INC, (B)(4)). ALTHOUGH SUCCESSFUL ON GAINING PURCHASE ON THE HERNIATED COIL, ON WITHDRAWING THE DEVICE IT CONSISTENTLY FAILED TO ENTER THE DISTAL END OF THE STENT AT THE LEVEL OF THE DISTAL MARKERS. THE COIL HERNIATED FURTHER UP THE MCA. NO MORE RETRIEVAL EFFORTS WERE MADE AND 4 MG ATEPLASE WAS ADMINISTERED LOCALLY THROUGH THE MICROCATHETER TO IMPROVE THE COMPROMISED FLOW IN THE MCA. THE PATIENT REMAINED ON HEPARIN. ON POST-OPERATIVE NEUROLOGICAL ASSESSMENT, THE ONLY DEFICIT WAS SOME SUBTLE DECREASE IN THE EXTENSORS OF THE RIGHT HAND. NO FURTHER INFORMATION COULD BE OBTAINED ABOUT THE CODMAN CERECYTE COIL, INCLUDING CATALOG AND LOT NUMBER OR DATE OF PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
429017 UNKNOWN CERECYTE MICROCOIL NEUROVASCULAR EMBOLIZATION DEVICE HCG MEDOS INTERNATIONAL SARL NA UNK

Patients

Seq Age Sex Outcome Treatment
1 43 YR